CAROLYNN HOWK: Open Payments
NPI 1295453009 · WAXAHACHIE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$912 in 41 payments from 17 companies in 2025. Trend: 2023 $47 · 2024 $663 · 2025 $912
Food & beverage: $912
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $120 |
| Genentech USA, Inc. | 4 | $120 |
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| Lilly USA, LLC | 5 | $101 |
| ABBVIE INC. | 4 | $78 |
| Biogen, Inc. | 3 | $69 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
| UCB, Inc. | 2 | $47 |
| GE HEALTHCARE | 2 | $37 |
| JAZZ PHARMACEUTICALS INC. | 1 | $35 |
Products named: NURTEC ODT, KESIMPTA, AMYVID, Ocrevus Zunovo, UBRELVY, Ocrevus, PONVORY, VUMERITY.
Industry payments across TX — which companies pay providers there.
